About: Seroprevalence of antibodies against SARS-CoV-2 among public community and health-care workers in Alzintan City of Libya

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Seroprevalence of antibodies against SARS-CoV-2 among public community and health-care workers in Alzintan City of Libya Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Seroprevalence of antibodies against SARS-CoV-2 among public community and health-care workers in Alzintan City of Libya
Creator	El-Arabi, Ali Erhouma, Esadk Kammon, Abdulwahab Mehemed, Taha Mohamed, Othman
source	MedRxiv
abstract	Abstract A study was conducted to determine the seroprevalence of antibodies against SARS-CoV-2 among public community and health care workers in Alzintan City, Libya. During the period from 2/4/2020 to 18/5/2020, a total of 219 blood samples were collected and analyzed for the presence of antibodies against SARS-CoV-2. Collection of samples were divided in two categories; random samples from public community and samples from health care workers belong to two Governmental hospitals and one private clinic. One Step Novel Coronavirus (COVID-19) IgM/IgG Antibody Test was used. Out of the 219 samples tested, 6 (2.74%) samples were seropositive for SARS-CoV-2. All health-care workers were tested negative. All positive cases were females and 5 of them aged between 44 to 75 years and one aged 32 years. The prevalence in young females ([≤]40 years) was 1.4% in total young females tested in the study and 1.75% in young females taken from public community. The prevalence in older females aged ( 40 years), was 11.1% in total females tested and 13.9% in females taken from public community. In conclusion, the preliminary investigation of SARS-CoV-2 revealed considerable prevalence in Alzintan City although the disease seems to be in its mild form. Active surveillance studies with high number of samples using both virological and serological tests are in urgent need.
has issue date	2020-05-26(xsd:dateTime)
bibo:doi	10.1101/2020.05.25.20109470
has license	medrxiv
sha1sum (hex)	d2cb42a01a631670871f22eed100a8af6f5beb04
schema:url	https://doi.org/10.1101/2020.05.25.20109470
resource representing a document's title	Seroprevalence of antibodies against SARS-CoV-2 among public community and health-care workers in Alzintan City of Libya
resource representing a document's body	covid:d2cb42a01a631670871f22eed100a8af6f5beb04#body_text
is schema:about of	named entity 'cases' named entity 'WORKERS' named entity 'ANTIBODIES' named entity 'SARS-COV-2' named entity 'COLLECTED' named entity 'SAMPLES' named entity 'USED' covid:arg/d2cb42a01a631670871f22eed100a8af6f5beb04 named entity 'conducted' named entity 'antibodies' named entity 'health-care' named entity 'determine' named entity 'workers' named entity 'Libya' named entity 'Libya' named entity 'Coronavirus' named entity 'antibodies' named entity 'All' named entity 'risk factor' named entity 'quantitative analysis' named entity 'COVID-19' named entity 'computed tomography' named entity 'health care' named entity 'Pneumonia' named entity 'virus' named entity 'preprint' named entity 'immune function' named entity 'rRT-PCR' named entity 'Blood samples' named entity 'rRT-PCR' named entity 'rRT-PCR' named entity 'phylogenetic analysis' named entity 'antigen' named entity 'clinical signs' named entity 'antibodies' named entity 'epidemiological' named entity 'Obstetrics and Gynecology' named entity 'antibiotics' named entity 'Libya' named entity 'serological tests' named entity 'private clinic' named entity 'SARS-CoV2' named entity 'assay' named entity 'health-care' named entity 'CBC' named entity 'virus' named entity 'nursing homes' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'health-care' named entity 'peer review' named entity 'gold standard' named entity 'antibodies' named entity 'Seroprevalence' named entity 'chest CT scan' named entity 'viral infection' named entity 'preprint' named entity 'COVID' named entity 'SARS-CoV-2' named entity 'IgG antibody' named entity 'COVID' named entity 'parainfluenza' named entity 'health care workers' named entity 'health-care' named entity 'doi' named entity 'health care workers' named entity 'SARS CoV' named entity 'SARS-CoV-2' named entity 'medRxiv' named entity 'IgG/IgM' named entity 'preprint' named entity 'medRxiv' named entity 'pneumonia' named entity 'virus' named entity 'peer review' named entity 'preprint' named entity 'antibodies' named entity 'medRxiv' named entity 'antibodies' named entity 'mycoplasma' named entity 'Blood Bank'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software